Effect of substituents on the metabolism of nitracrine in rat

References

• Al-Kassab S., Boyland E., Williams K. An enzyme from rat liver catalysing conjugations with glutathione. 2. Replacement of nitro groups. Biochemical Journal 1963; 87: 4–9
   PubMed Web of Science ®Google Scholar
• Alexander J., Wallin H., Rossland O. J., Solberg K. E., Holme J. A., Becker G., Andersson R., Grivas S. Formation of a glutathione conjugate and a semistable transportable glucuronide conjugate of N2-oxidized species of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat liver. Carcinogenesis 1991; 12: 2239–45
   PubMed Web of Science ®Google Scholar
• Denny W. A., Chambers D., Stewart G. M., Wilson W. R. Nitroacridines with selective toxicity towards hypoxic mammalian cells: synthesis and stability of tritiated derivatives. Journal of Labelled Compounds and Radiophamaceuticals 1985; 22: 995–1005
   Web of Science ®Google Scholar
• Gniazdowski M., Filipski J., Chorazy M. Nitracrine. Antibiotics V (part 2), F. E. Hahn. Springer, Berlin 1979; 275–297
   Google Scholar
• Hodgkiss R. J., Begg A. C., Middleton R. W., Parrick J., Stratford M. R. L., Wardman P., Wilson G. D. Fluorescent markers for hypoxic cells. A study of novel heterocyclic compounds that undergo bio-reductive binding. Biochemical Pharmacology 1991; 41: 533–541
   PubMed Web of Science ®Google Scholar
• Jackman L. M., Sternhell S. Applications of Nuclear Magnetic Resonance Spectroscopy in Organic Chemistry, 2nd edn. Pergamon, Oxford 1969; 202
   Google Scholar
• Kaspersen F. M., Van Boeckel C. A. A. A review of the methods of chemical synthesis of sulphate and glucuronide conjugates. Xenobiotica 1987; 17: 1451–1471
   PubMed Web of Science ®Google Scholar
• Lee H. H., Wilson W. R., Ferry D. M., Van Zijl P., Pullen S. M., Denny W. A. Hypoxia-selective antitumour agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide. Journal of Medicinal Chemistry 1996, in press
   Web of Science ®Google Scholar
• Pawlak J. W., Konopa J. In vitro binding of metabolically activated [14C]-ledakrine, or 1-nitro-9-14C-(3′-dimethylamino-N-propylamino)acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from at liver and HeLa cells. Biochemical Pharmacology 1979; 28: 3391–3402
   PubMed Web of Science ®Google Scholar
• Pawlak J. W., Pawlak K., Konopa J. The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of an 1-nitroacridine derivative, Ledakrin or nitracrine, with DNA and other macromolecules of mammalian or bacterial cells. Chemico-Biological Interactions 1983; 43: 151–173
   PubMed Web of Science ®Google Scholar
• Roberts P. B., Anderson R. F., Wilson W. R. Hypoxia-selective radiosensitization of mammalian cells by nitracrine, an electron-affinic DNA intercalator. International Journal of Radiation Biology 1987; 51: 641–654
   Web of Science ®Google Scholar
• Robertson I. G. C., Palmer B. D., Officer M., Siegers D. J., Paxton J. W., Shaw G. J. Cytosol mediated metabolism of the experimental antitumour agent acridine carboxamide to the 9-acridone derivative. Biochemical Pharmacology 1991; 42: 1879–1884
   PubMed Web of Science ®Google Scholar
• Stanley J. S., Jackson O., Miller D. W., Deluca D. C. Identification of the glutathione conjugate of 4-nitroquinoline-1-oxide formed in the reaction catalyzed by murine glutathione transferases. Carcinogenesis 1989; 10: 587–591
   PubMed Web of Science ®Google Scholar
• Stefanska B., Ledochowski A. Research on tumour-inhibiting compounds. Part XLVI. Derivatives of 1- and 3-nitro-9-aminoacridine. Roczniki Chemii 1968; 42: 1973–1980
   Google Scholar
• Turesky R. J., Bracco-Hammer I., Markovic J., Richli U., Kappeler A. M., Welti D. H. The contribution of N-oxidation to the metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat hepatocytes. Chemical Research in Toxicology 1990; 3: 524–535
   PubMed Web of Science ®Google Scholar
• Watts M. E., Dennis M. F., Stratford M. R. L., Wardman P. Glutathione-reactive nitro compounds as radiosensitizers: mechanistic and therapeutic implications. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1135–1138
   PubMed Web of Science ®Google Scholar
• Wilson W. R., Anderson R. F., Denny W. A. Hypoxia selective antitumour agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. Journal of Medicinal Chemistry 1989a; 32: 23–30
   PubMed Web of Science ®Google Scholar
• Wilson W. R., Denny W. A., Stewart G. M., Fenn A., Probert J. C. Reductive metabolism and hypoxia-selective toxicity of nitracrine. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1235–1238
   PubMed Web of Science ®Google Scholar
• Wilson W. R., Denny W. A., Twigden S. J., Baguley B. C., Probert J. C. Selective toxicity of nitracrine to hypoxic mammalian cells. British Journal of Cancer 1984; 49: 215–223
   PubMed Web of Science ®Google Scholar
• Wilson W. R., Thompson L. H., Anderson R. F., Denny W. A. Hypoxia-selective antitumour agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. Journal of Medicinal Chemistry 1989b; 32: 31–38
   PubMed Web of Science ®Google Scholar
• Wilson W. R., Van Zijl P., Denny W. A. Bis-bioreductive agents as hypoxia-selective cytotoxins: nitracrine N-oxide. International Journal of Radiation Oncology, Biology and Physics 1992; 22: 693–696
   PubMed Web of Science ®Google Scholar